Bibek Aryal, Surgeon-Scientist, Independent Researcher in Cancer Outcomes, shared on LinkedIn:
“Just out in Nature Medicine: our paper introducing the Value Cube, a three-dimensional framework for assessing value in global oncology.
About a year ago, Ophira Ginsburg, Dario Trapani and I started sketching this concept together.
We view this paper as a starting point – a conceptual foundation to build on, rather than a finished system.
Our next goal is to develop the Value Cube into a fully operational framework with measurable indicators, scoring, and real-world testing.
We hope to expand the team with colleagues from different regions and health-system settings by the end of 2026, and begin the next phase of the project in early 2027.
With this publication, we also want to make an open invitation to the global oncology community:
Please read the concept, challenge it, and improve it. If you are interested in helping shape the next phase of the Value Cube, reach out – we’d love to have you join us.”
Other articles featuring Bibek Aryal on OncoDaily.